Interpreting routine biochemistry in those aged over 65 years: A time for change

Maturitas

Volumn 66, Issue 1, 2010, Pages 39-45

  Bourdel Marchasson, Isabelle ^a,b   Laksir, Hamid ^a   Puget, Emilie ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b CNRS University Bordeaux Segalen   (France)

Author keywords

Biochemistry reference values; C reactive protein; Creatinine clearance; Elderly; Hyperkaliemia; Hypernatremia; Hypokalemia; Hyponatremia; Serum albumin; Total cholesterol

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; CREATININE; POTASSIUM; SERUM ALBUMIN; SODIUM; ALBUMINOID; BIOLOGICAL MARKER;

AGING; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; DIAGNOSTIC TEST; DISABILITY; DISEASE SEVERITY; HEART INFARCTION; HUMAN; HYPERNATREMIA; HYPONATREMIA; MORTALITY; MUSCLE ATROPHY; NUTRITIONAL STATUS; REVIEW; RISK ASSESSMENT; SCREENING TEST; AGED; BLOOD; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; FRAIL ELDERLY; GERIATRIC ASSESSMENT; METABOLISM; RISK FACTOR; SARCOPENIA;

AGED; ALBUMINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; COGNITION DISORDERS; CREATININE; DIAGNOSTIC TESTS, ROUTINE; FRAIL ELDERLY; GERIATRIC ASSESSMENT; HUMANS; POTASSIUM; RISK FACTORS; SARCOPENIA; SODIUM;

EID: 77950867026     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.02.004     Document Type: Review

References (73)

1. Boulat O., Krieg M.A., Janin B., Burckhardt P., Francioli P., and Bachmann C. Clinical chemistry variables in normal elderly and healthy ambulatory populations: comparison with reference values. Clin Chim Acta 272 (1998) 127-135
2. Carlsson L., Lind L., and Larsson A. Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology (2009)
3. Tietz N.W., Shuey D.F., and Wekstein D.R. Laboratory values in fit aging individuals-sexagenarians through centenarians. Clin Chem 38 (1992) 1167-1185
4. Willcox D.C., Willcox B.J., Wang N.C., He Q., Rosenbaum M., and Suzuki M. Life at the extreme limit: phenotypic characteristics of supercentenarians in Okinawa. J Gerontol A Biol Sci Med Sci 63 (2008) 1201-1208
5. Ramaroson H., Helmer C., Barberger-Gateau P., Letenneur L., and Dartigues J.F. Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus: données réactualisées de la cohorte Paquid (Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort). Rev Neurol (Paris) 159 (2003) 405-411
6. Bourdel-Marchasson I., Helmer C., Barberger-Gateau P., et al. Characteristics of undiagnosed diabetes in community-dwelling French elderly: the 3C study. Diabetes Res Clin Pract 76 (2007) 257-264
7. Millán-Calenti J, Tubío J, Pita-Fernández S, et al. Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality. Arch Gerontol Geriatr; in press.
8. Pham M., Pinganaud G., Richard-Harston S., Decamps A., and Bourdel-Marchasson I. Prospective audit of diabetes care and outcomes in a group of geriatric French care homes. Diabetes Metab 29 (2003) 251-258
9. Fraser C.G., Cummings S.T., Wilkinson S.P., et al. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 35 (1989) 783-786
10. Lips P., Duong T., Oleksik A., et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86 (2001) 1212-1221
11. Huber K.R., Mostafaie N., Stangl G., et al. Clinical chemistry reference values for 75-year-old apparently healthy persons. Clin Chem Lab Med 44 (2006) 1355-1360
12. Woloshin S., and Schwartz L.M. Distribution of C-reactive protein values in the United States. N Engl J Med 352 (2005) 1611-1613
13. Henny J. Interprétation des examens de laboratoire chez la personne âgée: effet de l'âge ou du vieillissement? (Interpretation of laboratory results of elderly subjects: effect of age or aging). Ann Pharm Fr 67 (2009) 173-181
14. Perazella M.A., and Mahnensmith R.L. Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 12 (1997) 646-656
15. Evans R.S., Lloyd J.F., Stoddard G.J., Nebeker J.R., and Samore M.H. Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother 39 (2005) 1161-1168
16. Dukas L., Schacht E., and Stahelin H.B. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures. Osteoporos Int 16 (2005) 1683-1690
17. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
18. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
19. Pedone C., Corsonello A., and Incalzi R.A. Estimating renal function in older people: a comparison of three formulas. Age Ageing 35 (2006) 121-126
20. Verhave J.C., Fesler P., Ribstein J., du Cailar G., and Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 46 (2005) 233-241
21. Pequignot R., Belmin J., Chauvelier S., et al. Renal function in older hospital patients is more accurately estimated using the Cockcroft-Gault formula than the modification diet in renal disease formula. J Am Geriatr Soc 57 (2009) 1638-1643
22. Passare G., Viitanen M., Torring O., Winblad B., and Fastbom J. Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Investig 24 (2004) 535-544
23. Tareen N., Martins D., Nagami G., Levine B., and Norris K.C. Sodium disorders in the elderly. J Natl Med Assoc 97 (2005) 217-224
24. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc 54 (2006) 345-353
25. Waikar S.S., Mount D.B., and Curhan G.C. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 122 (2009) 857-865
26. Whelan B., Bennett K., O'Riordan D., and Silke B. Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM 102 (2009) 175-182
27. Hoyle G.E., Chua M., and Soiza R.L. Prevalence of hyponatremia in elderly patients. J Am Geriatr Soc 54 (2006) 1473 author reply 73-4
28. Miller M., Morley J.E., and Rubenstein L.Z. Hyponatremia in a nursing home population. J Am Geriatr Soc 43 (1995) 1410-1413
29. Chua M., Hoyle G.E., and Soiza R.L. Prognostic implications of hyponatremia in elderly hospitalized patients. Arch Gerontol Geriatr 45 (2007) 253-258
30. Sajadieh A., Binici Z., Mouridsen M.R., Nielsen O.W., Hansen J.F., and Haugaard S.B. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 122 (2009) 679-686
31. Gankam Kengne F., Andres C., Sattar L., Melot C., and Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101 (2008) 583-588
32. Sandhu H.S., Gilles E., DeVita M.V., Panagopoulos G., and Michelis M.F. Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol 41 (2009) 733-737
33. Sasaki M., Yuzawa M., Saito T., et al. Clinical and laboratory features of hyponatremia-induced myopathy. Clin Exp Nephrol 11 (2007) 283-286
34. Adrogue H.J., and Madias N.E. Hypernatremia. N Engl J Med 342 (2000) 1493-1499
35. Bourdel-Marchasson I., Proux S., Dehail P., et al. One-year incidence of hyperosmolar states and prognosis in a geriatric acute care unit. Gerontology 50 (2004) 171-176
36. Chassagne P., Druesne L., Capet C., Menard J.F., and Bercoff E. Clinical presentation of hypernatremia in elderly patients: a case control study. J Am Geriatr Soc 54 (2006) 1225-1230
37. Bruce J.M., Harrington C.J., Foster S., and Westervelt H.J. Common blood laboratory values are associated with cognition among older inpatients referred for neuropsychological testing. Clin Neuropsychol 23 (2009) 909-925
38. Weinberg A.D., Pals J.K., McGlinchey-Berroth R., and Minaker K.L. Indices of dehydration among frail nursing home patients: highly variable but stable over time. J Am Geriatr Soc 42 (1994) 1070-1073
39. Adrogue H.J., and Madias N.E. Hyponatremia. N Engl J Med 342 (2000) 1581-1589
40. Juurlink D.N., Mamdani M.M., Lee D.S., et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351 (2004) 543-551
41. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
42. Goldfarb D.S. Hyperkalemia after the publication of RALES. N Engl J Med 351 (2004) 2448-2450 author reply 48-50
43. Witham M.D., Gillespie N.D., and Struthers A.D. Hyperkalemia after the publication of RALES. N Engl J Med 351 (2004) 2448-2450 author reply 48-50
44. Kleinfeld M., Borra S., Gavani S., and Corcoran A. Hypokalemia: are elderly females more vulnerable?. J Natl Med Assoc 85 (1993) 861-864
45. Franse L.V., Pahor M., Di Bari M., Somes G.W., Cushman W.C., and Applegate W.B. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 35 (2000) 1025-1030
46. Crop M.J., Hoorn E.J., Lindemans J., and Zietse R. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrol Dial Transplant 22 (2007) 3471-3477
47. Blondon H., Bechade D., Desrame J., and Algayres J.P. Secretory diarrhoea with high faecal potassium concentrations: a new mechanism of diarrhoea associated with colonic pseudo-obstruction? Report of five patients. Gastroenterol Clin Biol 32 (2008) 401-404
48. Traissac T., Salzmann M., Rainfray M., Emeriau J.P., and Bourdel-Marchasson I. Quelle signification pour le taux de cholestérol après 75 ans? (Significance of cholesterol levels in patients 75 years or older). Presse Med 34 (2005) 1525-1532
49. Staessen J.A., and Birkenhager W.H. Cognitive impairment and blood pressure: quo usque tandem abutere patientia nostra?. Hypertension 44 (2004) 612-613
50. Schatz I.J., Masaki K., Yano K., Chen R., Rodriguez B.L., and Curb J.D. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358 (2001) 351-355
51. Corti M.C., Guralnik J.M., Salive M.E., et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126 (1997) 753-760
52. Brescianini S., Maggi S., Farchi G., et al. Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc 51 (2003) 991-996
53. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., and Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 350 (1997) 1119-1123
54. Reuben D.B., Ix J.H., Greendale G.A., and Seeman T.E. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 47 (1999) 402-406
55. Bourdel-Marchasson I., and Lamouliate F. Normative value of investigations in elderly women. In: Rees M., and Keith L. (Eds). Medical problems in women over 70, when normative values do not apply (2007), Edition Abington: Informa 109-122
56. Carriere I., Dupuy A.M., Lacroux A., Cristol J.P., and Delcourt C. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc 56 (2008) 840-846
57. Zuliani G., Volpatol S., Romagnoni F., et al. Combined measurement of serum albumin and high-density lipoprotein cholesterol strongly predicts mortality in frail older nursing-home residents. Aging Clin Exp Res 16 (2004) 472-475
58. Casiglia E., Mazza A., Tikhonoff V., Scarpa R., Schiavon L., and Pessina A.C. Total cholesterol and mortality in the elderly. J Intern Med 254 (2003) 353-362
59. Hu P., Seeman T.E., Harris T.B., and Reuben D.B. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur studies of successful aging. J Am Geriatr Soc 51 (2003) 80-84
60. Okamura T., Hayakawa T., Hozawa A., et al. Lower levels of serum albumin and total cholesterol associated with decline in activities of daily living and excess mortality in a 12-year cohort study of elderly Japanese. J Am Geriatr Soc 56 (2008) 529-535
61. Visser M., Kritchevsky S.B., Newman A.B., et al. Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study. Am J Clin Nutr 82 (2005) 531-537
62. Ferrucci L., Penninx B.W., Volpato S., et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50 (2002) 1947-1954
63. Ferrucci L., Russo C.R., Lauretani F., Bandinelli S., and Guralnik J.M. A role for sarcopenia in late-life osteoporosis. Aging Clin Exp Res 14 (2002) 1-4
64. Payette H., Roubenoff R., Jacques P.F., et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc 51 (2003) 1237-1243
65. Straczek c, Ducimetiere P., Barberger-Gateau P., et al. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: The Three-City Study. J Am Geriatr Soc 58 (2010) 129-135
66. Hamer M., and Molloy G.J. Association of C-reactive protein and muscle strength in the English Longitudinal Study of Ageing. Age (Dordr) 31 (2009) 171-177
67. Barzilay J.I., Blaum C., Moore T., et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 167 (2007) 635-641
68. Yaffe K., Kanaya A., Lindquist K., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292 (2004) 2237-2242
69. Ble A., Windham B.G., Bandinelli S., et al. Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). Am J Cardiol 96 (2005) 991-995
70. Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med 68 (2001) 535-537
71. De Martinis M., Franceschi C., Monti D., and Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 579 (2005) 2035-2039
72. Cani P.D., Bibiloni R., Knauf C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008) 1470-1481
73. Reuben D.B., Judd-Hamilton L., Harris T.B., and Seeman T.E. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 51 (2003) 1125-1130